Terumo (OTCMKTS:TRUMY – Get Free Report) is one of 510 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its peers? We will compare Terumo to related companies based on the strength of its dividends, institutional ownership, analyst recommendations, earnings, profitability, valuation and risk.
Volatility & Risk
Terumo has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, Terumo’s peers have a beta of 2.57, indicating that their average share price is 157% more volatile than the S&P 500.
Insider and Institutional Ownership
40.3% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Dividends
Terumo pays an annual dividend of $0.06 per share and has a dividend yield of 0.4%. Terumo pays out 12.5% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.2% and pay out 47.3% of their earnings in the form of a dividend.
Valuation & Earnings
This table compares Terumo and its peers revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Terumo | $7.52 billion | $897.03 million | 32.96 |
| Terumo Competitors | $1.90 billion | $136.32 million | 5.94 |
Terumo has higher revenue and earnings than its peers. Terumo is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Profitability
This table compares Terumo and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Terumo | 9.31% | 7.03% | 4.83% |
| Terumo Competitors | -191.42% | -197.86% | -21.83% |
Analyst Ratings
This is a summary of current recommendations for Terumo and its peers, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Terumo | 0 | 0 | 0 | 2 | 4.00 |
| Terumo Competitors | 4330 | 10559 | 18358 | 840 | 2.46 |
As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 28.82%. Given Terumo’s peers higher probable upside, analysts clearly believe Terumo has less favorable growth aspects than its peers.
Summary
Terumo beats its peers on 9 of the 15 factors compared.
Terumo Company Profile
Terumo Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services. Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.
Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.
